Tata Memorial Centre Evidence Based Use of Nuclear medicine diagnostic and treatment modalities in cancer
Copyright © 2024 Copyright: © 2024 Indian Journal of Cancer..
ABSTRACT: PET/CT and radioisotope therapy are diagnostic and therapeutic arms of Nuclear Medicine, respectively. With the emergence of better technology, PET/CT has become an accessible modality. Diagnostic tracers exploring disease-specific targets has led the clinicians to look beyond FDG PET. Moreover, with the emergence of theranostic pairs of radiopharmaceuticals, radioisotope therapy is gradually making it's way into treatment algorithm of common cancers in India. We therefore would like to discuss in detail the updates in PET/CT imaging and radionuclide therapy and generate a consensus-driven evidence based document which would guide the practitioners of Oncology.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:61 |
|---|---|
| Enthalten in: |
Indian journal of cancer - 61(2024), Suppl 1 vom: 01. Jan., Seite S1-S28 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Puranik, Ameya D [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
0Z5B2CJX4D |
|---|
| Anmerkungen: |
Date Completed 04.03.2024 Date Revised 04.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.4103/ijc.ijc_52_24 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369145755 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369145755 | ||
| 003 | DE-627 | ||
| 005 | 20240304232752.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240301s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4103/ijc.ijc_52_24 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1316.xml |
| 035 | |a (DE-627)NLM369145755 | ||
| 035 | |a (NLM)38424680 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Puranik, Ameya D |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Tata Memorial Centre Evidence Based Use of Nuclear medicine diagnostic and treatment modalities in cancer |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.03.2024 | ||
| 500 | |a Date Revised 04.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 Copyright: © 2024 Indian Journal of Cancer. | ||
| 520 | |a ABSTRACT: PET/CT and radioisotope therapy are diagnostic and therapeutic arms of Nuclear Medicine, respectively. With the emergence of better technology, PET/CT has become an accessible modality. Diagnostic tracers exploring disease-specific targets has led the clinicians to look beyond FDG PET. Moreover, with the emergence of theranostic pairs of radiopharmaceuticals, radioisotope therapy is gradually making it's way into treatment algorithm of common cancers in India. We therefore would like to discuss in detail the updates in PET/CT imaging and radionuclide therapy and generate a consensus-driven evidence based document which would guide the practitioners of Oncology | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Radiopharmaceuticals |2 NLM | |
| 650 | 7 | |a Radioisotopes |2 NLM | |
| 650 | 7 | |a Fluorodeoxyglucose F18 |2 NLM | |
| 650 | 7 | |a 0Z5B2CJX4D |2 NLM | |
| 700 | 1 | |a Choudhury, Sayak |e verfasserin |4 aut | |
| 700 | 1 | |a Ghosh, Suchismita |e verfasserin |4 aut | |
| 700 | 1 | |a Dev, Indraja D |e verfasserin |4 aut | |
| 700 | 1 | |a Ramchandani, Varun |e verfasserin |4 aut | |
| 700 | 1 | |a Uppal, Abhishek |e verfasserin |4 aut | |
| 700 | 1 | |a Bhosale, Vikrant |e verfasserin |4 aut | |
| 700 | 1 | |a Palsapure, Abhishek |e verfasserin |4 aut | |
| 700 | 1 | |a Rungta, Rachita |e verfasserin |4 aut | |
| 700 | 1 | |a Pandey, Rakesh |e verfasserin |4 aut | |
| 700 | 1 | |a Khatri, Shweta |e verfasserin |4 aut | |
| 700 | 1 | |a George, Gemson |e verfasserin |4 aut | |
| 700 | 1 | |a Satamwar, Yogesh |e verfasserin |4 aut | |
| 700 | 1 | |a Maske, Rahul |e verfasserin |4 aut | |
| 700 | 1 | |a Agrawal, Archi |e verfasserin |4 aut | |
| 700 | 1 | |a Shah, Sneha |e verfasserin |4 aut | |
| 700 | 1 | |a Purandare, Nilendu C |e verfasserin |4 aut | |
| 700 | 1 | |a Rangarajan, Venkatesh |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Indian journal of cancer |d 1965 |g 61(2024), Suppl 1 vom: 01. Jan., Seite S1-S28 |w (DE-627)NLM000540609 |x 1998-4774 |7 nnns |
| 773 | 1 | 8 | |g volume:61 |g year:2024 |g number:Suppl 1 |g day:01 |g month:01 |g pages:S1-S28 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4103/ijc.ijc_52_24 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 61 |j 2024 |e Suppl 1 |b 01 |c 01 |h S1-S28 | ||